BBA
IHE icon

BLB&B Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

BLB&B Advisors’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-4,050
Closed -$204K – 289
2014
Q4 		$204K Buy
+4,050
New +$197K 0.04% 263

Other funds holding IHE

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
BCM
Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BWM
Braver Wealth Management Needham, Massachusetts $616M AUM 12.48% 1-Year Est. Return

BLB&B Advisors's IHE Position: Q1 2015 in Review

BLB&B Advisors sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2015, closing a stake of 4,050 shares — an estimated $204K sold.

BLB&B Advisors first reported a position in IHE in Q4 2014 and held it in 1 quarter. The position peaked at $204K in Q4 2014. 111 funds tracked by Wall St. Rank hold IHE as of Q1 2015.

  • BLB&B Advisors reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2015 after selling out during the quarter.
  • BLB&B Advisors sold 4,050 iShares US Pharmaceuticals ETF shares in Q1 2015, an estimated $204K.
  • BLB&B Advisors first reported a position in iShares US Pharmaceuticals ETF in Q4 2014 and held it in 1 quarter.
  • BLB&B Advisors's iShares US Pharmaceuticals ETF position peaked at $204K in Q4 2014.
  • 111 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2015.

Based on BLB&B Advisors's 13F filing for Q1 2015, filed 17 Apr 2015.